Improvement of Blood Plasmalogens and Clinical Symptoms in Parkinson's Disease by Oral Administration of Ether Phospholipids: A Preliminary Report

Introduction. Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease (AD). With the ageing of population, the frequency of PD is expected to increase dramatically in the coming decades. L-DOPA (1,3,4-dihydroxyalanine) is the most effective dr...

Full description

Saved in:
Bibliographic Details
Published in:Parkinsons Dis
Main Authors: Mawatari, Shiro, Ohara, Shinji, Taniwaki, Yoshihide, Tsuboi, Yoshio, Maruyama, Toru, Fujino, Takehiko
Format: Artigo
Language:Inglês
Published: Hindawi 2020
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7049862/
https://ncbi.nlm.nih.gov/pubmed/32148751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/2671070
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items